Chest Computed Tomography and Clinical Follow-Up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China
- PMID: 32692945
- PMCID: PMC7640627
- DOI: 10.1513/AnnalsATS.202004-324OC
Chest Computed Tomography and Clinical Follow-Up of Discharged Patients with COVID-19 in Wenzhou City, Zhejiang, China
Abstract
Rationale: Many clinical studies have focused on the epidemiological and clinical characteristics of inpatients with coronavirus disease (COVID-19). However, there are few reports about the clinical follow-up of discharged patients.Objectives: To describe the follow-up of patients with COVID-19 in Wenzhou City, Zhejiang, China.Methods: We retrospectively reviewed 4-week follow-ups in patients with COVID-19, including computed tomographic (CT) chest scanning, blood testing, and oropharyngeal-swab testing for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ribonucleic acid. The chest CT scans and blood tests were performed on the last day before discharge and 2 weeks and 4 weeks after discharge. The oropharyngeal-swab tests were performed at both 1 week and 2 weeks after discharge. Fifty-one patients with common COVID-19 were enrolled in the study. All the CT and clinical data were collected between January 23 and March 28, 2020.Results: Compared with the abnormalities found on the the last CT scans before discharge, the abnormalities in the lungs at the first and second follow-ups after discharge had been gradually absorbed. The cases with focal ground-glass opacity were reduced from 17.7% to 9.8% of cases. The cases with multiple ground-glass opacities decreased from 80.4% to 23.5%. The cases with consolidation were reduced from 49.0% to 2.0%. The cases with interlobular septal thickening were reduced from 80.4% to 35.3%. The cases with subpleural lines were reduced from 29.4% to 7.8%. The cases with irregular lines were reduced from 41.2% to 15.7%. The lung lesions of 25.5% patients were shown to be fully absorbed on the first CT scans after discharge, and the rate of lung recovery increased to 64.7% after the second follow-up. Nucleic-acid test results became recurrently positive in 17.6% of discharged patients, of whom only 33.3% complained of clinical symptoms. There were no differences in the characteristics of the last CT scans before discharge between the patients with recurrently positive test results and the patients with negative test results. The lung damage was fully absorbed in 55.6% of discharged patients with recurrence of positive test results for SARS-CoV-2 ribonucleic acid.Conclusions: The lung damage due to COVID-19 could be reversible for patients with common COVID-19. A few cases showed recurring positive results of nucleic-acid tests after discharge.
Keywords: COVID-19; SARS-CoV-2; computed tomographic imaging; follow-up; recurrently positive.
Figures
Similar articles
-
An uncommon manifestation of COVID-19 pneumonia on CT scan with small cavities in the lungs: A case report.Medicine (Baltimore). 2020 Jul 10;99(28):e21240. doi: 10.1097/MD.0000000000021240. Medicine (Baltimore). 2020. PMID: 32664179 Free PMC article.
-
Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.Eur J Nucl Med Mol Imaging. 2020 May;47(5):1275-1280. doi: 10.1007/s00259-020-04735-9. Epub 2020 Feb 28. Eur J Nucl Med Mol Imaging. 2020. PMID: 32107577 Free PMC article.
-
Radiographic and Clinical Features of Children With Coronavirus Disease (COVID-19) Pneumonia.Indian Pediatr. 2020 May 15;57(5):423-426. doi: 10.1007/s13312-020-1816-8. Epub 2020 Apr 7. Indian Pediatr. 2020. PMID: 32255437 Free PMC article.
-
Clinical characteristics of family-clustered onset of coronavirus disease 2019 in Jilin Province, China.Virulence. 2020 Dec;11(1):1240-1249. doi: 10.1080/21505594.2020.1816075. Virulence. 2020. PMID: 32930632 Free PMC article. Review.
-
Computed Tomography Features of Coronavirus Disease 2019 (COVID-19): A Review for Radiologists.J Thorac Imaging. 2020 Jul;35(4):211-218. doi: 10.1097/RTI.0000000000000527. J Thorac Imaging. 2020. PMID: 32427651 Review.
Cited by
-
Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information.medRxiv [Preprint]. 2021 Mar 26:2021.03.20.21253896. doi: 10.1101/2021.03.20.21253896. medRxiv. 2021. PMID: 33791733 Free PMC article. Preprint.
-
Reinfection or Reactivation of Severe Acute Respiratory Syndrome Coronavirus 2: A Systematic Review.Front Public Health. 2021 Jun 11;9:663045. doi: 10.3389/fpubh.2021.663045. eCollection 2021. Front Public Health. 2021. PMID: 34178920 Free PMC article. Review.
-
[Post-COVID syndrome: A reflection and opinion paper].Rev Esp Quimioter. 2021 Aug;34(4):269-279. doi: 10.37201/req/023.2021. Epub 2021 Apr 20. Rev Esp Quimioter. 2021. PMID: 33878844 Free PMC article. Review. Spanish.
-
Three-month outcomes of recovered COVID-19 patients: prospective observational study.Ther Adv Respir Dis. 2021 Jan-Dec;15:17534666211009410. doi: 10.1177/17534666211009410. Ther Adv Respir Dis. 2021. PMID: 33878961 Free PMC article.
-
Immunoglobulin Response and Prognostic Factors in Repeated SARS-CoV-2 Positive Patients: A Systematic Review and Meta-Analysis.Viruses. 2021 Apr 30;13(5):809. doi: 10.3390/v13050809. Viruses. 2021. PMID: 33946311 Free PMC article.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous